Introduction. Presentation with decreased fetal movement (DFM) is associated with fetal growth restriction and stillbirth. Some studies report that DFM is frequent among overweight or obese mothers. We aimed to determine the significance and associations of fetal movements in women of increased body size. Material and methods. This systematic review was conducted in accordance with the PRISMA statement and the protocol was registered with PROSPERO (CRD42016046352). Major databases were explored from inception to September 2017, using a predefined search strategy. We restricted inclusion to studies published in English and considered studies of any design that compared fetal movements in women of increased and normal body size. Two authors independently extracted data and assessed quality. Results. We included 23 publications from 19 observational studies; data were extracted from 10 studies. Increased maternal body size was not associated with altered perception of fetal movement (four studies, 95 women, very low-quality evidence), but was associated with increased presentation for DFM (two cohort studies, 20 588 women, OR 1.56, 95% CI 1.27-1.92: three case-control studies, 3445 women, OR 1.32, 95% CI 1.12-1.54; low-quality evidence). Among women with DFM, increased maternal body size was associated with increased risk of stillbirth and fetal growth restriction (one study, 2168 women, very low-quality evidence). Conclusions. This systematic review identified limited evidence that women with increased body size are more likely to present with DFM but do not have impaired perception of fetal movements. In women with DFM, increased body size is associated with worse pregnancy outcome, including stillbirth.
Introduction
Decreased fetal movement (DFM) is an important risk factor for stillbirth and timely assessment of complaints is recommended to reduce stillbirth (1, 2) . DFM is normally defined subjectively as maternal concern about a perceived reduction or cessation in fetal movements (1) .
In addition to stillbirth, DFM is associated with preterm birth (3), cesarean section for fetal distress (4), fetal ª 2017 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 97 (2018) [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] growth restriction (FGR) (5, 6) , small-for-gestational-age (SGA) (7) , and neurological impairment in offspring (8) . It has been hypothesized that when exposed to a worsening intrauterine environment, the fetus conserves energy by reducing movement, and this is supported by studies showing an association between DFM and placental pathology (7, (9) (10) (11) .
Maternal characteristics reported to be associated with DFM include, smoking, primiparity, advanced maternal age, anterior placenta, and maternal obesity (12, 13) . The majority of DFM cases go on to have a normal pregnancy outcome; hence, DFM appears to be a sensitive but non-specific indicator of fetal compromise. High-quality evidence to guide appropriate management of women presenting with DFM is scant (14) .
Maternal obesity is a known risk factor for adverse pregnancy outcomes, including stillbirth (15, 16) . A recent meta-analysis of studies in high-income countries demonstrated that obesity is the largest modifiable risk factor for stillbirth, surpassing even smoking (17) . Furthermore, there is a linear relation between maternal size, as measured by body mass index (BMI) and risk of stillbirth (15, 18) . Pregnant women who are overweight or obese appear to be more likely to present with DFM (10, 13) . However, a widely cited study concluded that perception of fetal movements is impaired by excess maternal abdominal fat, and that DFM may have greater clinical significance in normal weight women (13) . This study is influential in that it has been cited in a Cochrane review and in numerous practice guidelines and patient information for DFM (14) . To our knowledge, the evidence supporting this view has not been systematically evaluated.
Given that maternal obesity is now commonplace in developed countries and steadily increasing in the developing world (19, 20) , the contested nature of frequency and significance of DFM concerns in obese women highlights a need for a systematic review of the evidence regarding the influence of maternal body size on perception of fetal movements and whether or not obese pregnant women who present with DFM are at increased risk of adverse pregnancy outcomes.
Four questions are addressed in this systematic review. (1) Does increased maternal body size affect fetal movement and behavior? (2) Does increased maternal body size affect maternal perception or awareness of fetal movement? (3) Is increased maternal body size associated with altered presentation for decreased fetal movement? (4) Among women presenting with DFM, is increased maternal body size associated with risk of adverse fetal or neonatal outcome?
Material and methods
This systematic review was conducted in accordance with the PRISMA statement, and was registered in PROSPERO (no. CRD42016046352; http://www.crd.york.ac.uk/PROS PERO/).
Search strategy
We searched CINAHL, EMBASE, MEDLINE, PsycINFO and SCOPUS databases, using the search terms overweight, obese, BMI or body mass index, fetal movement, fetal activity, and fetal behavior, perception and awareness, including spelling variants. The search was restricted to studies involving humans and those published in English. There was no limit on year of publication. The search was last updated on 23 September 2017. We handsearched bibliographies of included studies, review papers and stillbirth conference abstracts to identify additional items. One author (BB) conducted the search and initial title and abstract screening. Records identified for full-text screening were reviewed by two authors (BB and AH, CM, LM or JT). Screening and eligibility assessments were performed using COVIDENCE (http://www.covide nce.org/). Conflicts were resolved by consensus or after consultation with a third author.
Inclusion criteria
Studies were eligible for inclusion if they included a defined exposure group (increased maternal size) and control group (normal maternal size), and reported on one or more of the following primary outcomes: (1) fetal movement and behavior as assessed by ultrasound or other objective device (rate of body movement, including movement types, measures of movement quality, and measures of behavioral state or development); (2) 
Data extraction and analysis
Data for primary and secondary outcomes were extracted independently by two authors using a customized form. Conflicts were resolved by consensus or following consultation with a third author. If data were missing, authors were contacted for additional information.
Secondary outcomes were as follows: for question 2, fetal movement concerns (as measured by validated inventories) and fetal movement counts; for question 3, delayed presentation with DFM, i.e. presentation >48 h of DFM or >24 h after absent fetal movements; and for question 4, neonatal unit admission, emergency cesarean section and low Apgar score (<4 at 1 min, <7 at 5 min).
Meta-analysis was planned using the inverse variance, fixed effects method in REVMAN (version 5.3), with inclusion of adjusted analyses where possible. Data from casecontrol and cohort studies were analyzed separately. If meta-analysis was not possible, a descriptive summary of study results is provided.
Quality of evidence
We assessed the risk of bias for each study and research question using a modified version of ROBINS-I for nonrandomized studies of intervention (see Supplementary material, Appendix S1) (21) . Two authors independently performed risk of bias assessments. Conflicts were resolved by consensus or by consultation with a third author.
We assessed the overall quality of evidence for each research question using the GRADE approach (22) . Two authors independently assessed quality of evidence. Conflicts were resolved by consensus or by consultation with a third author.
Results

Search results
Of 726 records identified, 609 were excluded following title and abstract screening, and a further 94 were excluded following full-text review (Figure 1 ). Of the remaining 23 publications, two were from one study (12, 23) , and three were from another study (10, 11, 24) . One publication (25) that reported on presentation with DFM was part of a larger cohort study (26) . Hence, 19 separate studies were included. Several of these reported on associations with BMI as a continuous variable but did not report outcomes for women of increased and normal body size (5, 9, 11, 24, (27) (28) (29) . Authors were contacted for additional data but this was provided for only one study (30) . Data were extracted from six studies for question 2, five for question 3, and one for question 4 ( (31) . There was moderate risk of bias for ascertainment of exposure and measurement of outcomes (Table 1 ). Higher motor activity was reported at 30-32 weeks and 36 weeks of gestation among fetuses of obese and overweight compared with normal weight women, but numerical data were not provided (31) .
Quality of evidence. There was insufficient evidence to determine the relation between maternal body size and fetal movement and behavior. Primary outcome. Four studies assessed the relation between maternal body size and perception of fetal movements, as measured by percentage of ultrasound observed fetal movements also perceived by mothers (30, (32) (33) (34) . These studies were either at moderate risk of bias or had incomplete information for risk of bias assessment in one or more domains ( (34) . Meta-analysis was not possible as only the study by Brown et al. (30) provided data in a form suitable for analysis.
Secondary outcomes. Two studies assessed the relation between maternal body size and maternal awareness of fetal movement and concern about fetal movements. Both studies were at low risk of bias. In a cross-sectional study of 691 women, Saastad et al. explored low maternal awareness and concerns about fetal movements using a questionnaire (35) . The authors reported that maternal overweight or obesity (n = 213), compared with BMI < 25 kg/m 2 (n = 445), was not associated with either "low awareness" of fetal movements [adjusted odds ratio (OR) 1.1, 95% CI 0.6-1.8] or concern about fetal movements (OR 0.90, 95% CI 0.70-1.2). Similarly, in a subsequent study of 692 women, Saastad et al. found that maternal overweight or obesity was not related to "low awareness" of fetal movements (OR 0.77, 95% CI 0.50-1.18) (36) . Following an intervention involving provision of information on fetal activity and monitoring, overweight and obese women remained significantly less likely than normal weight women to have "low awareness" of fetal movements but had increased likelihood of fetal movement concerns (36) .
Three studies compared maternal fetal movement counting between women of increased and normal body size (26, 37, 38) . Birger et al. studied 200 pregnant women, 150 of whom were hospital inpatients (37) . Mean (SD) hourly fetal movement counts were significantly lower in women who weighed ≥75 kg than in women who weighed 55-74 kg [22.0 (0.7) kg/m 2 vs. 29.0 (0.8) kg/m 2 , p = 0.001]. However, this study was at high risk of bias. For example, the counting method differed between inpatients and outpatients (the latter only counted movements during the evening) and no allowance was made for the likelihood that the inpatient group would have comprised more overweight women. In a cohort study of 1786 women, Winje et al. explored the relation between maternal characteristics and the time taken to count 10 fetal movements at a time when the mother knew the baby was active (38) . They reported that prepregnancy BMI ≥ 28 kg/m 2 , compared with BMI < 28 kg/m 2 , was associated with an increase in the mean count-to-ten time, and instances of more than 2 h to count 10 movements, but numerical data were not provided (38) . In a Studies included in quantitative synthesis (meta-analysis) (n = 10) Figure 1 . PRISMA flowchart. Twenty-three publications were identified as eligible but two were from one study (12, 23) , and three were from another study (10, 11, 24) . One publication (25) that reported on presentation with decreased fetal movements was part of a larger cohort study (26 subsequent cohort study of 1086 women, the same authors also reported an increase in count-to-ten time in women with BMI > 30 kg/m 2 , though the effect size was very small, amounting to an increase of <2 min (26) .
Quality of evidence. For the primary outcome of perception of fetal movement as assessed by ultrasound, there was very low-quality evidence suggesting that this is not different between women of increased and normal body size (see Supplementary material, Appendix S1).
Question 3. Is increased maternal body size associated with altered presentation for DFM?
Primary outcome. Ten studies (13 publications) reported on the association between maternal size and presentation with DFM (5, (9) (10) (11) (12) (13) 24, 25, 27, 28, 35) . One study, Saastad et al. (35) , was at low risk of bias, but all other studies were at moderate to serious risk of bias in one or more domains (Table 1) . Seven publications reported associations with BMI only as a continuous exposure (5, 9, 11, 24, 27, 28) . Of these, four studies reported no significant association between presentation with DFM and BMI, but did not provide numerical data (5, 27, 28) . One casecontrol study, Warrander et al. (9) , reported that median (range) BMI was not significantly different between women who presented with DFM and gave birth within 7 days (n = 36) and women without DFM (n = 36) (24. Figure 2 ). Two studies, reported stronger associations with greater degrees of maternal obesity (10, 13) . The case-control study by Tuffnell et al. (13) was performed nearly two decades before the other two case-control studies. However, in a post-hoc sensitivity analysis, exclusion of this study did not appreciably alter the results (OR 1.27, 95% CI 1.08-1.50).
Secondary outcome. In one study of 2168 women with uncomplicated pregnancy and DFM, those who
Odds ratio
Odds ratio
Odds ratio presented late (>48 h) were less likely to be overweight or obese (OR 0.7, 95% CI 0.6-0.9) (23).
Quality of evidence. For the primary outcome of presentation with DFM, there was low quality of evidence for a positive association between presentation with DFM and increased maternal body size (see Supplementary material, Appendix S1).
Question 4. Among pregnant women with DFM, is increased maternal body size associated with risk of adverse fetal or neonatal outcome?
Primary outcomes. Four studies (five publications) reported on the relation between outcomes following a presentation with DFM and maternal body size (5, 7, 10, 23, 24) . All studies were at moderate risk of bias or had incomplete information for risk of bias assessment in one or more domains (Table 1) . Tveit et al. conducted a case-control study within a prospective cohort (2168 women with DFM at ≥28 weeks of gestation in otherwise uncomplicated pregnancy) and reported on two of the prespecified primary outcomes, namely, FGR (customized birthweight <10th centile) and stillbirth (FGR cases n = 271; stillbirth cases n = 69) (23) . In multivariable analysis, among women presenting with DFM, those with FGR and stillbirth were more likely to have prepregnancy BMI > 25 kg/m 2 (FGR OR 1.6, 95% CI 1.2-2.1; stillbirth OR 1.8, 95% CI 1.0-3.2).
The remaining three studies reported on associations with BMI only as a continuous exposure (5, 7, 10, 24) . O'Sullivan et al. and Dutton et al. found no association between BMI and risk of stillbirth, but these studies were not adequately powered to assess this outcome (5,7). Pagani et al. reported that among women presenting with DFM, those with an SGA infant (birthweight <10th population centile) compared with appropriate for gestational age infant had a slightly lower BMI, but the risk of increased maternal body size for cases was not provided (10, 24) . No studies reported on the relation between maternal size and neonatal death or hypoxic-ischemic encephalopathy following presentation with DFM.
Secondary outcomes. We were unable to locate any studies that reported on the relation between maternal body size and neonatal intensive care unit admission, emergency cesarean section, or low Apgar score among women presenting with DFM.
Quality of evidence. For the primary outcomes of FGR and stillbirth, there was very low-quality evidence of a positive association with increased maternal body size among women presenting with DFM (see Supplementary material, Appendix S1).
Discussion
Our findings are in agreement with the accepted view that pregnant women with increased body size are more likely to present with DFM, although the effect size is small. In contrast, we did not find evidence to support the view that perception of fetal movements is impaired in overweight or obese mothers. Additionally, our findings challenge the view that DFM is of lesser clinical significance in obese or overweight women and indeed found limited evidence that the converse may be true.
The quality of available evidence to explore the questions included in this review was low, very low or non-existent. We found insufficient evidence to determine if increased maternal body size affects fetal movement or behavior. Very low-quality evidence suggests that perception of fetal movement is similar in women of increased and normal body size. Low-quality evidence suggests that women with increased body size are more likely to present with DFM than women of normal body size. Very low-quality evidence suggests that among women presenting with DFM, fetuses of women with increased body size have increased risk of growth restriction and stillbirth. There is insufficient evidence to determine if increased maternal body size is associated with increased likelihood of neonatal death or hypoxic-ischemic encephalopathy following presentation with DFM.
We were generally unable to find evidence that fetal movement is affected by increased maternal body size, although one study reported a delayed trajectory of development in fetuses of overweight and obese mothers compared with normal weight mothers (31) . Delayed development of fetal behavioral states has been observed in fetuses of diabetic women (39, 40) , as has DFM (41) . Alterations in development of fetal behavior have also been described in the context of FGR (42) (43) (44) . Maternal obesity is associated with gestational diabetes, and FGR (45) . Finally, obesity is associated with changes in placental cell turnover and function, which are also seen in DFM (46) . A plausible explanation for the small increase in rates of presentation for DFM among heavier women is an actual reduction in fetal movement in some overweight and obese women. Further studies of fetal behavior are required in women with uncomplicated obesity.
Historically, inferences about reduced perception of fetal movements in maternal subgroups have been made on the basis of their increased presentation with DFM (13, 28) . Tuffnell et al. stated that maternal perception of fetal movements is impaired by increased abdominal fat but did not assess either abdominal fat or maternal perception of fetal movement (13) . We assessed evidence for an effect of maternal overweight on perception using empirical studies that compared maternally perceived movements with movements observed contemporaneously via ultrasound. Four studies reported no influence of increased maternal body size perception of fetal movement (3, 30, 32, 34) .
Ultrasound studies have consistently reported wide variation in perception of fetal movements among pregnant women. For example, in a recent study by Brown et al., the rate of movements perceived ranged from 2% to 82%. Reports on the relative influence of maternal characteristics such as parity, gestational age, placental location and liquor volume on maternal perception of fetal movements are conflicting (47) . Characteristics of fetal movements themselves appear to influence detection by the pregnant woman. For example, fetal movements that are stronger, of longer duration, more complex, or that occur during a period when the fetus is in an active behavioral state are more readily perceived (30, 33, 34, 48) .
We included some studies of fetal movement counting in this review. Fetal movement counts are also known to vary widely between women, but are relatively stable within individual pregnancies over time (26) . Included studies found no relation between "low awareness" of fetal movements or delay in seeking assessment following a concern about fetal movements and raised maternal BMI (35, 36) . Available studies of "low awareness" of fetal movement were conducted in Norway where population obesity is relatively low and there is a well-funded public healthcare system (49) . Further studies are needed in other settings.
A systematic review reported indirect evidence that introduction of measures to improve maternal awareness of fetal movements and promote prompt presentation for antenatal assessment in the instance of DFM may improve outcomes (2) . Investigation of DFM complaints can aid in identifying newly developed pregnancy complications, particularly SGA (5, 7, 50) . Undiagnosed SGA is a significant contributor to fetal death and improved identification of SGA has been proposed as a means to reduce stillbirths (51, 52) . SGA can be difficult to diagnose in obese pregnant women and serial ultrasounds are recommended where accurate symphysis-fundal height measurement cannot be achieved. A Swedish study reported significantly reduced incidence of stillbirth in small babies who had been identified as such during pregnancy (53) .
A problem common to studies in this review was the lack of adequate adjustment for potential confounding factors. Maternal obesity is associated with many factors that increase the risk of adverse pregnancy outcome including: higher parity (54), lower educational attainment, smoking and single marital status (55) . In some developed country settings, maternal overweight is associated with demographic factors that can act as barriers to accessing health care such as low socio-economic status (56) . Future studies of presentation with DFM should be adequately adjusted for such variables and ideally report them to facilitate meta-regression analysis. Two large trials are ongoing and likely to provide high-quality evidence on management and outcomes of DFM (57, 58) .
A strength of this review is the inclusion of several important clinical questions that have direct implications for patient care. Limitations include, few studies, moderate to high risk of bias, and absence of data for several outcomes. For outcomes following presentation with DFM, some studies were underpowered to detect differences in stillbirth and others did not use customized centiles to define SGA. Customized birthweight centiles have been shown to improve detection of pregnancies and infants at increased risk of morbidity and mortality (59, 60) . In addition, studies of fetal movement perception in women who have a BMI > 35 kg/m 2 are lacking. In conclusion, we report that perception of fetal movement does not appear to be affected by maternal body size, although further studies are needed, particularly in women with a BMI > 35 kg/m 2 . Future research should explore the possibility of differences in fetal behavior in association with maternal obesity. Meta-analysis suggests that increased maternal body size is associated with increased presentation for DFM. What evidence there is, suggests that among women with DFM, those with raised BMI may be at increased risk of adverse pregnancy outcomes. We conclude that concerns about fetal movements in women with raised BMI have the same or perhaps greater clinical significance and should not be disregarded due to assumptions about impaired perception, though further studies are needed.
